Evidence map›Paper›PMID 18508095›Full record

ArticleNeuropharmacology2008

Calcium release via activation of presynaptic IP3 receptors contributes to kainate-induced IPSC facilitation in rat neocortex.

Seena S Mathew, John J Hablitz

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Promoter-Specific Effects of DREADD Modulation on Hippocampal Synaptic Plasticity and Memory Formation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  9. Organelle-Specific Sensors for Monitoring CaFrontiers in synaptic neuroscience · 2016
    Review
  10. Article
  11. Article
  12. Article
  13. Kainate receptor-induced retrograde inhibition of glutamatergic transmission in vasopressin neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
  14. Therapeutic potential of kainate receptors.CNS neuroscience & therapeutics · 2011
    Review
  15. Article
  16. Review
  17. Glia-dependent switch of kainate receptor presynaptic action.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2010
    Article
  18. Article
  19. Robust short-latency perisomatic inhibition onto neocortical pyramidal cells detected by laser-scanning photostimulation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2009
    Article
  20. GABA vesicles at synapses: are there 2 distinct pools?The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Seena S MathewDepartment of Neurobiology and Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
John J Hablitz
University of Alabama at Birmingham · US

Funding

Alabama Neuroscience Blueprint Core CenterP30NS057098 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SWEATT, JOHN DAVID · 2006 to 2010
$9.5M
UAB Neuroscience Core CenterP30NS047466 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STANDAERT, DAVID G. · 2005 to 2019
$8.5M
NEOCORTICAL EPILEPSY DURING DEVELOPMENTR01NS022373 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HABLITZ, JOHN J. · 1986 to 2011
$2.7M
NINDS NIH HHS NS22373NINDS NIH HHS P30 NS047466NINDS NIH HHS P30 NS057098NINDS NIH HHS P30-NS47466NINDS NIH HHS P30-NS57098NINDS NIH HHS R01 NS022373
6 · The paper itself

Abstract

We examined the mechanisms of kainate (KA) induced modulation of GABA release in rat prefrontal cortex. Pharmacologically isolated IPSCs were recorded from visually identified layer II/III pyramidal cells using whole-cell patch clamp techniques. KA produced an increase in evoked IPSC amplitude at low nanomolar concentrations (100-500 nM). The frequency but not the amplitude of miniature (m) IPSCs was also increased. The GluR5 subunit selective agonist (RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid (ATPA) caused an increase in mIPSC frequency whereas (3S,4aR,6S,8aR)-6-(4-carboxyphenyl)methyl-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid (LY382884), a selective GluR5 subunit antagonist, inhibited this facilitation. Philanthotoxin-433 (PhTx) blocked the effect of KA, indicating involvement of Ca(2+)-permeable GluR5 receptors. No IPSC facilitation was seen when Ca(2+) was omitted from the bathing solution. Facilitation was observed when slices were preincubated in ruthenium red or high concentrations of ryanodine, but was inhibited with application of thapsigargin. The IP3 receptor (IP3R) antagonists diphenylboric acid 2-amino-ethyl ester (2-APB) (15 microM) and Xestospongin C (XeC) blocked IPSC facilitation. These results show that activation of KA receptors (KARs) on GABAergic nerve terminals results is linked to intracellular Ca(2+) release via activation of IP3, but not ryanodine, receptors. This represents a new mechanism of presynaptic modulation whereby Ca(2+) entry through Ca(2+)-permeable GluR5 subunit containing KARs activates IP3Rs receptors leading to an increase in GABA release.

Indexed as

AnimalsBoron CompoundsCalciumDose-Response Relationship, DrugDrug InteractionsElectric StimulationExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsInhibitory Postsynaptic PotentialsInositol 1,4,5-Trisphosphate ReceptorsIn Vitro TechniquesKainic AcidMacrocyclic CompoundsNeocortexNeuronsNicotinic Antagonists2-aminoethoxydiphenyl borateBoron CompoundsCalciumdelta-philanthotoxinExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsInositol 1,4,5-Trisphosphate ReceptorsKainic AcidMacrocyclic CompoundsNicotinic AntagonistsOxazolesPolyaminesxestospongin C

Identifiers

PMID18508095
PMCPMC2580077
OpenAlexW2039112179

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.